Pharmaceutical Executive-10-01-2009

How proper site activation and site enrollment can help you get the most from clinical trials.

All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.

Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.

Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?

Executives should embrace design to discover new markets and find new ways to server customers.

How a small competitor benefited from the use of interactive marketing.

Leaders manage their time and focus their resources by limiting unwanted interruptions.

Game-changers can create competitive advantages for pharmaceutical companies and products.